June 28, 2005; 64 (12) Special Article
Practice Parameter: Therapies for essential tremor [RETIRED]
Report of the Quality Standards Subcommittee of the American Academy of Neurology
T. A. Zesiewicz, R. Elble, E. D. Louis, R. A. Hauser, K. L. Sullivan, R. B. Dewey, W. G. Ondo, G. S. Gronseth, W. J. Weiner
First published June 22, 2005, DOI: https://doi.org/10.1212/01.WNL.0000163769.28552.CD
T. A. Zesiewicz
From the Department of Neurology and Parkinson’s Disease and Movement Disorders Center (Drs. Zesiewicz and Hauser, and K.L. Sullivan), University of South Florida, Tampa; Department of Neurology (Dr. Elble), Southern Illinois University School of Medicine, Springfield; GH Sergievsky Center and Department of Neurology (Dr. Louis), College of Physicians and Surgeons, Columbia University, New York, NY; University of Texas Southwestern Medical Center (Dr. Dewey), Dallas; Department of Neurology (Dr. Ondo), Baylor College of Medicine, Houston, TX; Department of Neurology (Dr. Gronseth), University of Kansas Medical Center, Kansas City; and Department of Neurology (Dr. Weiner), University of Maryland School of Medicine, Baltimore.
R. Elble
From the Department of Neurology and Parkinson’s Disease and Movement Disorders Center (Drs. Zesiewicz and Hauser, and K.L. Sullivan), University of South Florida, Tampa; Department of Neurology (Dr. Elble), Southern Illinois University School of Medicine, Springfield; GH Sergievsky Center and Department of Neurology (Dr. Louis), College of Physicians and Surgeons, Columbia University, New York, NY; University of Texas Southwestern Medical Center (Dr. Dewey), Dallas; Department of Neurology (Dr. Ondo), Baylor College of Medicine, Houston, TX; Department of Neurology (Dr. Gronseth), University of Kansas Medical Center, Kansas City; and Department of Neurology (Dr. Weiner), University of Maryland School of Medicine, Baltimore.
E. D. Louis
From the Department of Neurology and Parkinson’s Disease and Movement Disorders Center (Drs. Zesiewicz and Hauser, and K.L. Sullivan), University of South Florida, Tampa; Department of Neurology (Dr. Elble), Southern Illinois University School of Medicine, Springfield; GH Sergievsky Center and Department of Neurology (Dr. Louis), College of Physicians and Surgeons, Columbia University, New York, NY; University of Texas Southwestern Medical Center (Dr. Dewey), Dallas; Department of Neurology (Dr. Ondo), Baylor College of Medicine, Houston, TX; Department of Neurology (Dr. Gronseth), University of Kansas Medical Center, Kansas City; and Department of Neurology (Dr. Weiner), University of Maryland School of Medicine, Baltimore.
R. A. Hauser
From the Department of Neurology and Parkinson’s Disease and Movement Disorders Center (Drs. Zesiewicz and Hauser, and K.L. Sullivan), University of South Florida, Tampa; Department of Neurology (Dr. Elble), Southern Illinois University School of Medicine, Springfield; GH Sergievsky Center and Department of Neurology (Dr. Louis), College of Physicians and Surgeons, Columbia University, New York, NY; University of Texas Southwestern Medical Center (Dr. Dewey), Dallas; Department of Neurology (Dr. Ondo), Baylor College of Medicine, Houston, TX; Department of Neurology (Dr. Gronseth), University of Kansas Medical Center, Kansas City; and Department of Neurology (Dr. Weiner), University of Maryland School of Medicine, Baltimore.
K. L. Sullivan
From the Department of Neurology and Parkinson’s Disease and Movement Disorders Center (Drs. Zesiewicz and Hauser, and K.L. Sullivan), University of South Florida, Tampa; Department of Neurology (Dr. Elble), Southern Illinois University School of Medicine, Springfield; GH Sergievsky Center and Department of Neurology (Dr. Louis), College of Physicians and Surgeons, Columbia University, New York, NY; University of Texas Southwestern Medical Center (Dr. Dewey), Dallas; Department of Neurology (Dr. Ondo), Baylor College of Medicine, Houston, TX; Department of Neurology (Dr. Gronseth), University of Kansas Medical Center, Kansas City; and Department of Neurology (Dr. Weiner), University of Maryland School of Medicine, Baltimore.
R. B. Dewey Jr
From the Department of Neurology and Parkinson’s Disease and Movement Disorders Center (Drs. Zesiewicz and Hauser, and K.L. Sullivan), University of South Florida, Tampa; Department of Neurology (Dr. Elble), Southern Illinois University School of Medicine, Springfield; GH Sergievsky Center and Department of Neurology (Dr. Louis), College of Physicians and Surgeons, Columbia University, New York, NY; University of Texas Southwestern Medical Center (Dr. Dewey), Dallas; Department of Neurology (Dr. Ondo), Baylor College of Medicine, Houston, TX; Department of Neurology (Dr. Gronseth), University of Kansas Medical Center, Kansas City; and Department of Neurology (Dr. Weiner), University of Maryland School of Medicine, Baltimore.
W. G. Ondo
From the Department of Neurology and Parkinson’s Disease and Movement Disorders Center (Drs. Zesiewicz and Hauser, and K.L. Sullivan), University of South Florida, Tampa; Department of Neurology (Dr. Elble), Southern Illinois University School of Medicine, Springfield; GH Sergievsky Center and Department of Neurology (Dr. Louis), College of Physicians and Surgeons, Columbia University, New York, NY; University of Texas Southwestern Medical Center (Dr. Dewey), Dallas; Department of Neurology (Dr. Ondo), Baylor College of Medicine, Houston, TX; Department of Neurology (Dr. Gronseth), University of Kansas Medical Center, Kansas City; and Department of Neurology (Dr. Weiner), University of Maryland School of Medicine, Baltimore.
G. S. Gronseth
From the Department of Neurology and Parkinson’s Disease and Movement Disorders Center (Drs. Zesiewicz and Hauser, and K.L. Sullivan), University of South Florida, Tampa; Department of Neurology (Dr. Elble), Southern Illinois University School of Medicine, Springfield; GH Sergievsky Center and Department of Neurology (Dr. Louis), College of Physicians and Surgeons, Columbia University, New York, NY; University of Texas Southwestern Medical Center (Dr. Dewey), Dallas; Department of Neurology (Dr. Ondo), Baylor College of Medicine, Houston, TX; Department of Neurology (Dr. Gronseth), University of Kansas Medical Center, Kansas City; and Department of Neurology (Dr. Weiner), University of Maryland School of Medicine, Baltimore.
W. J. Weiner
From the Department of Neurology and Parkinson’s Disease and Movement Disorders Center (Drs. Zesiewicz and Hauser, and K.L. Sullivan), University of South Florida, Tampa; Department of Neurology (Dr. Elble), Southern Illinois University School of Medicine, Springfield; GH Sergievsky Center and Department of Neurology (Dr. Louis), College of Physicians and Surgeons, Columbia University, New York, NY; University of Texas Southwestern Medical Center (Dr. Dewey), Dallas; Department of Neurology (Dr. Ondo), Baylor College of Medicine, Houston, TX; Department of Neurology (Dr. Gronseth), University of Kansas Medical Center, Kansas City; and Department of Neurology (Dr. Weiner), University of Maryland School of Medicine, Baltimore.
Practice Parameter: Therapies for essential tremor [RETIRED]
Report of the Quality Standards Subcommittee of the American Academy of Neurology
T. A. Zesiewicz, R. Elble, E. D. Louis, R. A. Hauser, K. L. Sullivan, R. B. Dewey, W. G. Ondo, G. S. Gronseth, W. J. Weiner
Neurology Jun 2005, 64 (12) 2008-2020; DOI: 10.1212/01.WNL.0000163769.28552.CD
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 64 no. 12 2008-2020
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published June 22, 2005.
Article Versions
- Previous version (June 22, 2005 - 12:56).
- You are viewing the most recent version of this article.
Copyright & Usage:
© 2005
Author Disclosures
- T. A. Zesiewicz, MD,
- R. Elble, MD, PhD, FAAN,
- E. D. Louis, MD, MS, FAAN,
- R. A. Hauser, MD, MBA, FAAN,
- K. L. Sullivan, MSPH,
- R. B. Dewey Jr, MD, FAAN,
- W. G. Ondo, MD,
- G. S. Gronseth, MD and
- W. J. Weiner, MD, FAAN
- T. A. Zesiewicz, MD,
- R. Elble, MD, PhD, FAAN,
- E. D. Louis, MD, MS, FAAN,
- R. A. Hauser, MD, MBA, FAAN,
- K. L. Sullivan, MSPH,
- R. B. Dewey Jr, MD, FAAN,
- W. G. Ondo, MD,
- G. S. Gronseth, MD and
- W. J. Weiner, MD, FAAN
- From the Department of Neurology and Parkinson’s Disease and Movement Disorders Center (Drs. Zesiewicz and Hauser, and K.L. Sullivan), University of South Florida, Tampa; Department of Neurology (Dr. Elble), Southern Illinois University School of Medicine, Springfield; GH Sergievsky Center and Department of Neurology (Dr. Louis), College of Physicians and Surgeons, Columbia University, New York, NY; University of Texas Southwestern Medical Center (Dr. Dewey), Dallas; Department of Neurology (Dr. Ondo), Baylor College of Medicine, Houston, TX; Department of Neurology (Dr. Gronseth), University of Kansas Medical Center, Kansas City; and Department of Neurology (Dr. Weiner), University of Maryland School of Medicine, Baltimore.
- Address correspondence and reprint requests to the American Academy of Neurology, 1080 Montreal Avenue, St. Paul, MN 55116.
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Special Article
Evidence-based guideline update: Treatment of essential tremorReport of the Quality Standards Subcommittee of the American Academy of NeurologyT.A. Zesiewicz, R.J. Elble, E.D. Louis et al.Neurology, October 19, 2011 -
Brief Communications
Botulinum toxin treatment of essential head tremorR. Pahwa, K. Busenbark, E. F. Swanson-Hyland et al.Neurology, April 01, 1995 -
BRIEF COMMUNICATION
Deep brain stimulation for essential tremorJ. P. Hubble, K.L. Busenbark, S. Wilkinson et al.Neurology, April 01, 1996 -
Views & Reviews
Laryngeal DystoniaMultidisciplinary Update on Terminology, Pathophysiology, and Research PrioritiesKristina Simonyan, Julie Barkmeier-Kraemer, Andrew Blitzer et al.Neurology, April 15, 2021